# MADIT ASIA Cardiac Resynchronization Trial

> **NCT01872234** · PHASE3 · TERMINATED · sponsor: **Boston Scientific Corporation** · enrollment: 1 (actual)

## Conditions studied

- Congestive Heart Failure
- Left Bundle Branch Block
- Heart Failure, Systolic

## Interventions

- **DEVICE:** Two-lead CRT-P

## Key facts

- **NCT ID:** NCT01872234
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-02
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** The study encountered significant difficulties in patient enrollment.
- **Last updated:** 2014-04-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01872234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01872234, "MADIT ASIA Cardiac Resynchronization Trial". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01872234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*